Ypsomed
Philip Etter possesses extensive experience in product management and engineering within the medical and healthcare industries. Currently serving as Alliance & Partner Manager and Director of Product Management BGMS at Ypsomed AG since 2014, Philip leads cross-functional teams in the development and realization of glucose monitoring systems while managing strategic supplier relationships and conducting market analyses. Prior roles at forteq Healthcare and Roche Diabetes Care included senior positions focusing on product management, project leadership, and mechanical design, where Philip was instrumental in optimizing product designs, leading project teams, and enhancing customer communications. Philip holds a Bachelor of Business Administration and a Bachelor of Science in Mechanical Engineering, complemented by a Federal Vocational Education and Training Diploma in Precision Mechanics.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.